Coagulant Therapeutics presents data on activated protein C (APC) exosite-specific nanobody library at the American Society of Hematology (ASH) 2022 Annual Meeting.
The oral presentation describes the unique library of APC nanobodies and its potential as a source for novel treatments of diseases including trauma, hemophilia, ischemia and sepsis. SAN FRANCISCO, Dec. 11, 2022 /PRNewswire/ — Coagulant Therapeutics Corporation, a privately held company focused on the design, development and commercialization of therapeutics targeting the coagulation cascade and …